Beth Sheppard 800AZBio Board of Directors

Elizabeth Sheppard, MBA, HT (ASCP)

Senior Director, Market Access

Ventana Medical Systems, Inc./ Roche Tissue Diagnostics

Elizabeth (Beth) Sheppard, MBA, HT (ASCP) was  elected to the AZBio  Board of Directors in   April of 2016.  She is  currently Senior Director, Market Access, Ventana Medical Systems, Inc./ Roche Tissue Diagnostics in Tucson, Arizona. She provides management oversight of Market Access projects, External Quality Assessment program participation, Guidelines, Standards and Strategic Health Economics and Pricing support for Roche affiliates.

Presently, she is a voting member and committee representative with the Clinical Laboratory Standards Institute (CLSI) , member of the ISO/TC212 Clinical Laboratory Testing and in vitro Test Systems, US Technical Advisory Group and advisor to a College of American Pathologists Histotechnology committee.

Her educational background includes degrees in Histotechnology, Biology/Business and a Master’s in Business Administration.

Prior to her current position, Ms. Sheppard worked in both private and academic management of Anatomic Pathology laboratories.

Her faculty experience consists of Clinical Experience Advisor, and Instructor, State University of New York at Cobleskill, Faculty, Wake Forest University School of Medicine, Fundamental of Pathology and Adjunct Faculty at Pima Community College. Ms. Sheppard has authored numerous publications and is a frequent invited speaker at state, regional, national and international conferences.